Analyst Research: Acura Pharmaceuticals Inc (ACUR.O)

ACUR.O on Consolidated Issue listed on NASDAQ Capital Market

0.78USD
30 Sep 2014
Price Change (% chg)

$-0.01 (-0.76%)
Prev Close
$0.79
Open
$0.79
Day's High
$0.80
Day's Low
$0.77
Volume
43,393
Avg. Vol
74,627
52-wk High
$2.23
52-wk Low
$0.68

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
ACUR: Due Diligence Review: Forensic Earnings and Valuation 30 Sep 2014 New Constructs, LLC 9 25.00
Thomson Reuters Stock Report - ACURA PHARMACEUTICALS, INC. (ACUR-O) 30 Sep 2014 Thomson Reuters Stock Report 11 25.00
ValuEngine Rating and Forecast Report for ACUR 28 Sep 2014 ValuEngine, Inc. 11 25.00
Acura Pharmaceuticals 27 Sep 2014 S&P Capital IQ Quantitative Report 11 127.00
ACURA PHARMACEUTICALS INC (ACUR) - REPORT FOR ACTIVE TRADERS 26 Sep 2014 Pechala's Reports 1 25.00
ACURA PHARMACEUTICALS INC (ACUR) 12-months forecast 26 Sep 2014 Pechala's Reports 1 15.00
Acura Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 26 Sep 2014 Reuters Investment Profile 12 20.00
Value Graph: ACURA PHARMACEUT -- ACUR 25 Sep 2014 Ford Investor Services, Inc. 1 12.00
TheStreet.com Ratings Stock Report For: ACURA PHARMACEUTICALS INC (ACUR) 20 Sep 2014 TheStreet.com Ratings 5 10.00
 
Name Age Since Current Position

Robert Jones

55 2011 President, Chief Executive Officer, Director

Peter Clemens

61 2004 Chief Financial Officer, Senior Vice President, Secretary

Robert Seiser

50 2004 Vice President, Corporate Controller and Treasurer

J. Bradley Rivet

60 2011 Vice President - Marketing

Albert Brzeczko

57 2009 Vice President -Technical Affairs
Search Stocks